Skip to main content

CORRECTION article

Front. Aging Neurosci., 05 January 2023
Sec. Neurocognitive Aging and Behavior
Volume 14 - 2022 | https://doi.org/10.3389/fnagi.2022.1125201

Corrigendum: Associations between blood-based biomarkers of Alzheimer's disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau

This article is a correction to:

  1. Associations between blood-based biomarkers of Alzheimer’s disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau

    1. Read original article
\nPei-Hao Chen,,Pei-Hao Chen1,2,3Sang-I LinSang-I Lin4Ying-Yi LiaoYing-Yi Liao5Wei-Ling Hsu,Wei-Ling Hsu4,6Fang-Yu Cheng Fang-Yu Cheng4*
  • 1Department of Neurology, MacKay Memorial Hospital, Taipei, Taiwan
  • 2Department of Medicine, MacKay Medical College, New Taipei City, Taiwan
  • 3Graduate Institute of Mechanical and Electrical Engineering, National Taipei University of Technology, Taipei, Taiwan
  • 4Institute of Long-Term Care, MacKay Medical College, New Taipei City, Taiwan
  • 5Department of Gerontological Health Care, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan
  • 6Center of Dementia Care, MacKay Memorial Hospital, New Taipei City, Taiwan

A corrigendum on
Associations between blood-based biomarkers of Alzheimer's disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau

by Chen, P.-H., Lin, S.-I., Liao, Y.-Y., Hsu, W.-L., and Cheng, F.-Y. (2022). Front. Aging Neurosci. 14:981632. doi: 10.3389/fnagi.2022.981632

In the published article, an author's name was incorrectly written as Sang-Yi Lin. The correct spelling is Sang-I Lin.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: plasma biomarker, cognition, gait speed, Alzheimer's disease, motoric cognitive risk syndrome

Citation: Chen P-H, Lin S-I, Liao Y-Y, Hsu W-L and Cheng F-Y (2023) Corrigendum: Associations between blood-based biomarkers of Alzheimer's disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau. Front. Aging Neurosci. 14:1125201. doi: 10.3389/fnagi.2022.1125201

Received: 16 December 2022; Accepted: 19 December 2022;
Published: 05 January 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Chen, Lin, Liao, Hsu and Cheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Fang-Yu Cheng, yes fycheng@mmc.edu.tw

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.